| 書目名稱 | Essentials of Atrial Fibrillation | | 編輯 | Yee Guan Yap,A John Camm | | 視頻video | http://file.papertrans.cn/316/315595/315595.mp4 | | 概述 | Contains only the most up-to-date, targeted, clinically relevant content to suit physicians’ needs.Expertly written by globally recognized, established key thought leaders in the cardiology field.Effe | | 圖書封面 |  | | 描述 | This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. ?Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events. | | 出版日期 | Book 2014 | | 關鍵詞 | Atrial Fibrillation; Cardiology; Direct factor Xa inhibitors; Oral Anticoagulants; Rivaroxaban; pharmacot | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-907673-98-6 | | isbn_softcover | 978-1-85873-438-5 | | isbn_ebook | 978-1-907673-98-6 | | copyright | Springer Healthcare 2014 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-17 05:29
發(fā)表于 2025-3-21 16:26:17
